The Executive Director, NPHCDA, Dr Faisal Shuaib, made the disclosure at the Presidential Task Force (PTF) on COVID-19 briefing on Monday in Abuja. “As earlier communicated, Nigeria is no longer expecting the 100,000 doses of the Pfizer/BIONtech vaccine through the COVAX facility but has been allocated about 16 million doses of the AstraZeneca vaccine. “This was based on epidemiological and equity assessment done by WHO. “These vaccine will be arriving in batches, starting by late February,“ Shuaib said. He noted that Nigeria was considered one of the countries ready to receive the Pfizer vaccine but, because the distribution intended to achieve public health value, it was not practical to provide every capable country with the vaccine due to its limited quantity.